WAI CHUN BIOTEC (00660) announced that the group expects to record a net loss not exceeding HK$13 million for the year ending June 30, 2025, representing a substantial decrease compared to the net loss of approximately HK$65.7 million for the year ending June 30, 2024. The significant reduction in losses is primarily attributed to decreased impairment losses on non-financial assets during the reporting period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.